Rising energy and freight costs, coupled with supply chain disruptions and dependency on Chinese APIs, are straining India's pharma sector. These factors raise the risk of drug shortages and increased drug prices.

Supply chain disruptions, higher energy and freight prices, and reliance on Chinese APIs are squeezing margins, raising the risk of higher drug prices and potential shortages.